Additive bio-manufacturing: 3D printing for medical recovery and human enhancement

Arianna Ferrari; António Moniz; Martina Baumann; Christopher Coenen; Leonhard Hennen; Helge Torgersen; Lisa van Bodegom; Barend van der Meulen; Karen Riisgaard

doi:10.2861/923327

Additive bio-manufacturing: 3D printing for medical recovery and human enhancement

Arianna Ferrari (Editor/Coordinator), António Moniz, Martina Baumann, Christopher Coenen, Leonhard Hennen, Helge Torgersen, Lisa van Bodegom, Barend van der Meulen, Karen Riisgaard

Research output: Book/Report › Commissioned report › peer-review

20 Downloads (Pure)

Abstract

Additive bio-manufacturing (bio-AM) is defined here as the use of 3D printing for medical purposes or non-therapeutic “human enhancement”, whether they involve the production of biological material or not. It includes any application for rehabilitating, supporting or augmenting biological functionality. The impacts of bio-AM are uncertain, and it is not clear which actions may be required to foster responsible development of the technology.
This study responds to these gaps in our knowledge by describing the state of the art and future development prospects, analysing their wide-ranging impacts - including social, ethical and economic aspects - and identifying key policy challenges along with options to respond to them. Key challenges are to avoid an incoherent, piecemeal adaptation of regulatory frameworks, to support responsible development that improves citizens’ lives, and to foster public participation and citizen-driven innovation. The European RRI approach could provide a useful platform for responding to these challenges, emphasising inclusiveness and co-creation by a wide variety of stakeholder groups, including public participation.

Original language	English
Place of Publication	Brussels
Publisher	STOA European Parliament
Commissioning body	European Parliament
Number of pages	132
ISBN (Print)	978-92-846-3148-3
DOIs	https://doi.org/10.2861/923327
Publication status	Published - Jul 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.2861/923327Licence: Unspecified

3d bio-printing for medical and enhancement purposes-QA0118636ENNFinal published version, 888 KBLicence: Unspecified

O papel da Manufatura Aditiva na competitividade das empresas do setor Metalúrgico e Metalomecânico num contexto de mudança
Crespo, J. P. S. G. (President of Jury), Cândido, A. C. (Main Examiner), Costa, L. B. (Main Examiner), Moniz, A. B. (Member of Jury), Barata, J. (Member of Jury) & Boavida, N. (Member of Jury)
Sept 2016 → Jul 2022
Activity: Examination
Board of the Observatory of Technology Assessment
Moniz, A. B. (Chair), Candeias, M. S. G. S. (Member) & Boavida, N. (Member)
Mar 2015 → Dec 2025
Activity: Other › Types of External academic engagement - Membership of external research organisation

Cite this

@book{643cf95a2967443f8e19ed0ab538a7ac,

title = "Additive bio-manufacturing: 3D printing for medical recovery and human enhancement",

abstract = "Additive bio-manufacturing (bio-AM) is defined here as the use of 3D printing for medical purposes or non-therapeutic “human enhancement”, whether they involve the production of biological material or not. It includes any application for rehabilitating, supporting or augmenting biological functionality. The impacts of bio-AM are uncertain, and it is not clear which actions may be required to foster responsible development of the technology. This study responds to these gaps in our knowledge by describing the state of the art and future development prospects, analysing their wide-ranging impacts - including social, ethical and economic aspects - and identifying key policy challenges along with options to respond to them. Key challenges are to avoid an incoherent, piecemeal adaptation of regulatory frameworks, to support responsible development that improves citizens{\textquoteright} lives, and to foster public participation and citizen-driven innovation. The European RRI approach could provide a useful platform for responding to these challenges, emphasising inclusiveness and co-creation by a wide variety of stakeholder groups, including public participation.",

author = "Arianna Ferrari and Ant{\'o}nio Moniz and Martina Baumann and Christopher Coenen and Leonhard Hennen and Helge Torgersen and \{van Bodegom\}, Lisa and \{van der Meulen\}, Barend and Karen Riisgaard",

note = "info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID\%2FSOC\%2F04647\%2F2013/PT\# UID/SOC/04647/2013",

year = "2018",

month = jul,

doi = "10.2861/923327",

language = "English",

isbn = "978-92-846-3148-3",

publisher = "STOA European Parliament",

}

TY - BOOK

T1 - Additive bio-manufacturing

T2 - 3D printing for medical recovery and human enhancement

AU - Moniz, António

AU - Baumann, Martina

AU - Coenen, Christopher

AU - Hennen, Leonhard

AU - Torgersen, Helge

AU - van Bodegom, Lisa

AU - van der Meulen, Barend

AU - Riisgaard, Karen

A2 - Ferrari, Arianna

N1 - info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UID%2FSOC%2F04647%2F2013/PT# UID/SOC/04647/2013

PY - 2018/7

Y1 - 2018/7

N2 - Additive bio-manufacturing (bio-AM) is defined here as the use of 3D printing for medical purposes or non-therapeutic “human enhancement”, whether they involve the production of biological material or not. It includes any application for rehabilitating, supporting or augmenting biological functionality. The impacts of bio-AM are uncertain, and it is not clear which actions may be required to foster responsible development of the technology. This study responds to these gaps in our knowledge by describing the state of the art and future development prospects, analysing their wide-ranging impacts - including social, ethical and economic aspects - and identifying key policy challenges along with options to respond to them. Key challenges are to avoid an incoherent, piecemeal adaptation of regulatory frameworks, to support responsible development that improves citizens’ lives, and to foster public participation and citizen-driven innovation. The European RRI approach could provide a useful platform for responding to these challenges, emphasising inclusiveness and co-creation by a wide variety of stakeholder groups, including public participation.

AB - Additive bio-manufacturing (bio-AM) is defined here as the use of 3D printing for medical purposes or non-therapeutic “human enhancement”, whether they involve the production of biological material or not. It includes any application for rehabilitating, supporting or augmenting biological functionality. The impacts of bio-AM are uncertain, and it is not clear which actions may be required to foster responsible development of the technology. This study responds to these gaps in our knowledge by describing the state of the art and future development prospects, analysing their wide-ranging impacts - including social, ethical and economic aspects - and identifying key policy challenges along with options to respond to them. Key challenges are to avoid an incoherent, piecemeal adaptation of regulatory frameworks, to support responsible development that improves citizens’ lives, and to foster public participation and citizen-driven innovation. The European RRI approach could provide a useful platform for responding to these challenges, emphasising inclusiveness and co-creation by a wide variety of stakeholder groups, including public participation.

U2 - 10.2861/923327

DO - 10.2861/923327

M3 - Commissioned report

SN - 978-92-846-3148-3

BT - Additive bio-manufacturing

PB - STOA European Parliament

CY - Brussels

ER -

Additive bio-manufacturing: 3D printing for medical recovery and human enhancement

Abstract

UN SDGs

Access to Document

Fingerprint

Activities

O papel da Manufatura Aditiva na competitividade das empresas do setor Metalúrgico e Metalomecânico num contexto de mudança

Board of the Observatory of Technology Assessment

Cite this